CHRISTOPHER BOWE JOINS SCRIP AS US HEALTHCARE ANALYST

LONDON – Monday, 27 September 2010 – Scrip, the market-leading international pharmaceutical and biotech information provider, has appointed Christopher Bowe to the post of US Healthcare Analyst as part of its expansion of an analyst team to serve subscribers.

With his appointment, Bowe will help expand the high-value original and topical analysis of pharmaceutical and healthcare industries, policy and regulation, as well as engage and serve customers through Scrip’s tailored project research advisory services of Ask the Analyst. He will be available to media to comment on trends, news and insights derived from original Scrip analysis. His work will cross a diverse constituency ranging from industry, to the financial analyst community, to researchers to communications and consultancy groups.

Christopher joins Scrip and its highly-acclaimed, award-winning news, analysis and data services with more than two decades of experience working in and commentating on the global pharma and biotech industry.

“Christopher has a wealth of industry knowledge and experience and we are delighted that he has joined the analyst team,” says Dr Philip Smith, Research Director at Informa, publishers of Scrip. “Our users will benefit from his in-depth knowledge of the US healthcare market gained from extensive experience in the senior journalist roles and more recently, as a senior advisor to top management at a major US pharmaceutical company.”

Scrip Intelligence, Clinica MedTech News and the Regulatory Affairs Pharma and Medtech titles will all feature Christopher’s content ranging across the North American pharma and medtech sectors and including analysis of current issues in business strategy, policy, regulatory affairs, R&D, technology and company intelligence.

Bowe’s appointment also strengthens Scrip’s commitment to client research support, which is available through the Ask the Analyst services.

“It is an honour to join the team at Scrip,” says Bowe, who will be based in New York, USA. “I look forward to engaging subscribers and providing analysis that leaders and decisionmakers want and need in order to gain competitive insights. The world of healthcare is changing so quickly and original analysis is of high importance.

“I am also very excited about the power of analysis and data through access to the extensive intelligence within the Scrip group,” he says.

“Christopher’s arrival is an exciting milestone for Scrip’s business intelligence services, particularly in the US,” continues Dr Smith. “We are setting a new standard in information provision with the recent launch of our cutting-edge SCRIP Intelligence news, analysis and data and Ask the Analyst services. Christopher’s experience and knowledge of the industry will help to ensure that the Scrip range of titles remains second-to-none in serving the intelligence needs of those working in and with the global pharma and biotech sectors.”

In his most recent role, Christopher served as Counselor, Strategic Affairs for Schering-Plough working directly with CEO Fred Hassan as well as his senior management team. Prior to that, he served as US Healthcare Correspondent and Chicago Correspondent for the Financial Times and as Chicago Correspondent for Dow Jones Newswires.